The Role of Bioequivalence in Generic vs. Brand-Name Medications

Generic drugs undergo rigorous bioequivalence studies to demonstrate that they release the active pharmaceutical ingredient (API) into the bloodstream at the same rate and concentration as the innovator brand. Regulated health authorities mandate that generic formulations display identical safety, strength, dosage form, and clinical performance, providing cost-effective treatment alternatives without compromising patient outcomes.